The structural and functional properties of HLA-DQ and -DR molecules that c
onfer susceptibility to several common autoimmune diseases, such as type 1
diabetes, rheumatoid arthritis and multiple sclerosis, have been defined. T
he relevant polymorphisms directly affect interaction with peptides, which
provides strong support for the hypothesis that these diseases are peptide-
antigen driven. Several studies indicate that structural modifications of p
eptides can affect MHC class II binding and/or TCR recognition and should b
e considered in the analysis of T cell responses in autoimmune diseases.